Context Polypharmacy is widely used in the treatment of schizophrenia, although it is
believed to have major adverse effects on the well-being of patients. Objective To …

Introduction Patients with schizophrenia have an elevated mortality risk compared to the
general population, with cardiovascular-related deaths being the leading cause. The role of …

The Medical Journal of Australia Page 1 MJA • Volume 190 Number 4 • 16 February 2009 S39
PATHWAYS TO SCHIZOPHRENIA The Medical Journal of Australia ISSN: 0025729X 16 …

Purpose Mortality among schizophrenia patients is substantially higher than in the general
population. The aim of this study was to investigate, in a nationwide cohort of suicidal …

BackgroundThe Edinburgh High-Risk Study is designed to explore the underlying
pathogenesis of schizophrenia. AimsTo establish the sample characteristics of the first 100 …

Importance Although schizophrenia is associated with several age-related disorders and
considerable cognitive impairment, it remains unclear whether the risk of dementia is higher …

Results from a 40-year followup study of psychotic patients are presented to illustrate some
of the major findings and unanswered questions about excess mortality in schizophrenia …

Gender differences in schizophrenia have been reported in different aspect of the course of
disease and may urge special clinical interventions for female patients. Current literature …

We aimed to evaluate suicide risk across the life-course in severe mental illnesses (SMI)
including schizophrenia. Using survival analysis, we compared suicide risk in cohorts of …

Background The declining incidence of schizophrenia observed in several countries is
believed by many to merely reflect methodological problems in the studies performed. We …